Skip to Main Content

Author Details

Ana Lleo
Humanitas University
2003
156
47
PMIDPaper TitleJournal TitlePublished Year
37676683Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry.Hepatology2024
36672457Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence.Cancers (Basel)2023
37632080Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients.Viruses2023
37592292Cancer-on-chip: a 3D model for the study of the tumor microenvironment.J Biol Eng2023
37157905Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival.Liver Int2023
37312635Patient-reported quality of care in primary sclerosing cholangitis.Liver Int2023
37046842Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer Treatment.Cancers (Basel)2023
36588300Immune checkpoint inhibitors in malignancies after liver transplantation: Better safe or sorry?Liver Int2023
36695552Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: A case report.Mod Rheumatol Case Rep2023
36468575Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe.Eur J Gastroenterol Hepatol2023
36684809PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales.J Transl Autoimmun2023
36576057Clinical features and management issues of NAFLD-related HCC: what we know so far.Expert Rev Gastroenterol Hepatol2023
34586589Antimitochondrial Antibodies: from Bench to Bedside.Clin Rev Allergy Immunol2022
35738508Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target.J Hepatol2022
35410851Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury.Dig Liver Dis2022
35582674Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges.World J Gastroenterol2022
35632557Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases.Vaccines (Basel)2022
35816898A change of paradigm in PBC: Pursuing normal alkaline phosphatase.EBioMedicine2022
35591841An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study.Arch Med Sci2022
36615062Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization.J Clin Med2022
36440259Histological and serological features of acute liver injury after SARS-CoV-2 vaccination.JHEP Rep2022
36421345Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360).Curr Oncol2022
36555840Relationship between Epithelial-to-Mesenchymal Transition and Tumor-Associated Macrophages in Colorectal Liver Metastases.Int J Mol Sci2022
36150526Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.Gastroenterology2022
36270716Contemporary Epidemiology of Primary Biliary Cholangitis.Clin Liver Dis2022
35962757Recommendations for histological criteria of autoimmune hepatitis from the international AIH pathology: Validation on a monocentric cohort.Liver Int2022
35932095Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid.Liver Int2022
35317947Meta-analysis on prognostic value of KRAS mutation in resected mass-forming cholangiocarcinoma.Eur J Surg Oncol2022
35092335Is immunosuppression truly associated with worse outcomes in autoimmune hepatitis patients with COVID-19?Liver Int2022
35303556The added value of artificial intelligence to LI-RADS categorization: A systematic review.Eur J Radiol2022
35340108High prevalence of porto-sinusoidal vascular disease in patients with constantly elevated gamma-glutamyl transferase levels.Liver Int2022
35167909Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.J Hepatol2022
33323757Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool.Eur J Gastroenterol Hepatol2021
33881366Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life study.Expert Opin Drug Saf2021
33681748Real-world experience with obeticholic acid in patients with primary biliary cholangitis.JHEP Rep2021
33922972Risk Stratification of Cholangiocarcinoma Patients Presenting with Jaundice: A Retrospective Analysis from a Tertiary Referral Center.Cancers (Basel)2021
34425712Targeting the RANK/RANKL pathway in autoimmune disease and malignancy: future perspectives.Expert Rev Clin Immunol2021
34830823Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors.Cancers (Basel)2021
33942335Letter to the Editor: Are We Confident That Primary Biliary Cholangitis Liver-Related Mortality Is Higher in Males?Hepatology2021
34102015What gastroenterologists should know about SARS-CoV 2 vaccine: World Endoscopy Organization perspective.United European Gastroenterol J2021
33966352High prevalence of multidrug-resistant bacteria in patients with pyogenic liver abscess following liver cancer loco-regional treatments.Liver Int2021
33966344Experimental liver models: From cell culture techniques to microfluidic organs-on-chip.Liver Int2021
33306247High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting.J Viral Hepat2021
31537031The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review.Semin Liver Dis2020
31863485Letter to the Editor: Might Denosumab Fit in Primary Biliary Cholangitis Treatment?Hepatology2020
32071906Surgical Treatment of Hepatocholangiocarcinoma: A Systematic Review.Liver Cancer2020
32107758Postsustained Virological Response Management in Hepatitis C Patients.Semin Liver Dis2020
33308474Primary biliary cholangitis.Lancet2020
33330813Identifying medical professionals at risk for in-hospital COVID-19 infection: a snapshot during a "tsunami" highlighting unexpected risks.Glob Health Med2020
33271804Transcriptional Differences for COVID-19 Disease Map Genes between Males and Females Indicate a Different Basal Immunophenotype Relevant to the Disease.Genes (Basel)2020
  • 1 - 50 of 156

Recommended Authors

Min Kyu Kang
Yeungnam University College of Medicine
Career Start Year 2018
Number of shared co-authors 0
Bryan M McCauley
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2016
Number of shared co-authors 4
Khashayar Asadi
Austin Hospital
Career Start Year 2015
Number of shared co-authors 0
Anouar Teriaky
Western University
Career Start Year 2011
Number of shared co-authors 0
Neil Rajoriya
Queen Elizabeth Hospital Birmingham
Career Start Year 2009
Number of shared co-authors 1
Joseph J Larson
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2009
Number of shared co-authors 7
Bita V Naini
university of california los angeles Medical Center
Career Start Year 2008
Number of shared co-authors 0
Christopher Koh
Clinical Research Section
Career Start Year 2008
Number of shared co-authors 0
Jung Gil Park
Yeungnam University Hospital
Career Start Year 2006
Number of shared co-authors 0
Thomas Longerich
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2004
Number of shared co-authors 1
Won Young Tak
Kyungpook National University
Career Start Year 2001
Number of shared co-authors 1
Curtis K Argo
University of Virginia
Career Start Year 2000
Number of shared co-authors 0
Ali Zarrinpar
College of Medicine, University of Florida
Career Start Year 1999
Number of shared co-authors 0
Jayant A Talwalkar
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 2
Frank Tacke
Charite-Universitatsmedizin Berlin
Career Start Year 1999
Number of shared co-authors 1
Michael P Curry
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 1997
Number of shared co-authors 0
Peter St??rkel
Cliniques Universitaires Saint-Luc (CUSL)
Career Start Year 1996
Number of shared co-authors 0
Theo Heller
National Institute of Diabetes and Digestive and Kidney Diseases
Career Start Year 1996
Number of shared co-authors 1
Kyong-Mi Chang
Corporal Michael J Crescenz VA Medical Center
Career Start Year 1996
Number of shared co-authors 2
Chi Ma
Affiliated Yantai Yuhuangding Hospital of Qingdao University
Career Start Year 1995
Number of shared co-authors 0
Tim F Greten
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 1
Jong Young Choi
Ajou University School of Medicine
Career Start Year 1994
Number of shared co-authors 0
Andrew D Clouston
University of Queensland
Career Start Year 1993
Number of shared co-authors 0
Raymond T Chung
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1992
Number of shared co-authors 2
Christine M Hunt
Duke University Medical Center and Durham Veterans Affairs Health Care System
Career Start Year 1990
Number of shared co-authors 0
Arun J Sanyal
Virginia Commonwealth University
Career Start Year 1989
Number of shared co-authors 2
Grace L Su
University of Washington
Career Start Year 1989
Number of shared co-authors 0
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1989
Number of shared co-authors 4
Yoshiyuki Takei
Mie University
Career Start Year 1988
Number of shared co-authors 0
Zachary Goodman
Center for Liver Diseases, Inova Fairfax Hospital
Career Start Year 1975
Number of shared co-authors 1

Collaborators

Pietro Invernizzi
Center for Autoimmune Liver Diseases, University of Milano-Bicocca
Co-authored papers 56
Merrill Eric Gershwin
Allergy and Clinical Immunology, University of California at Davis
Co-authored papers 45
Gideon M Hirschfield
University of Toronto
Co-authored papers 17
Ross L Coppel
Nursing and Health SciencesMonash UniversityClaytonVictoriaAustralia.
Co-authored papers 11
Michael F Seldin
University of California davis
Co-authored papers 5
Maurizio Cecconi
IRCCS, Humanitas Research Hospital
Co-authored papers 5
Christopher I Amos
Baylor College of Medicine
Co-authored papers 4
Katherine A Siminovitch
University of Toronto, Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 4
Andre Franke
Institute of Clinical Molecular Biology, Kiel University
Co-authored papers 3
Konstantinos N Lazaridis
Mayo Clinic
Co-authored papers 3
Peter K Gregersen
Co-authored papers 3
Alessandro Repici
Co-authored papers 3
Daniele Cusi
Institute of Biomedical Technologies, National Research Council of Italy
Co-authored papers 3
Gang Xie
Chaohu Hospital Affiliated to Anhui Medical University
Co-authored papers 3
Brian D Juran
Mayo Clinic
Co-authored papers 2
Richard N Sandford
University of Cambridge
Co-authored papers 2
Arndt Vogel
Clinic for Gastroenterology, Medical University Hannover
Co-authored papers 2
Yafang Li
University of Michigan ann arbor
Co-authored papers 2
George F Mells
University of Cambridge
Co-authored papers 2
Daniele Prati
Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico
Co-authored papers 2
Roberta Maselli
Co-authored papers 1
Cesare Hassan
Co-authored papers 1
Sara Lupoli
Co-authored papers 1
Flora Peyvandi
Co-authored papers 1
Dakai Zhu
The Institute for Clinical and Translational Research, Baylor College of Medicine
Co-authored papers 1
Roberta Pastorelli
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Co-authored papers 1
Filippo Martinelli Boneschi
Co-authored papers 1
Casey S Greene
Co-authored papers 1
Malte C R??hlemann
Institute of Clinical Molecular Biology, Christian-Albrechts-Universitat zu Kiel
Co-authored papers 1
Jeanette Erdmann
Co-authored papers 1
Release 1.2